GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shandong Ruifeng Chemical Co 300243.SZ · CNY

Materials · Shenzhen · 🇨🇳 China

Compare

14.33

+0.84%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.97bn

FY2016FY2025

Net income

CN¥30.3m

FY2016FY2025

Free cash flow

CN¥99.4m

FY2016FY2025

Shareholders' equity

CN¥1.14bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥1.97bnCN¥2.00bnCN¥1.78bnCN¥1.83bnCN¥1.86bnCN¥1.30bnCN¥1.21bnCN¥1.45bnCN¥1.10bnCN¥873.5m
Gross profitCN¥298.1mCN¥282.0mCN¥308.2mCN¥294.4mCN¥341.5mCN¥272.4mCN¥290.9mCN¥319.6mCN¥194.3mCN¥223.8m
Research and developmentCN¥8.6mCN¥108.8mCN¥100.7mCN¥99.4mCN¥93.0mCN¥63.0mCN¥55.9mCN¥56.8mCN¥46.6mCN¥33.2m
Operating incomeCN¥79.6mCN¥32.0mCN¥92.3mCN¥57.8mCN¥131.4mCN¥103.0mCN¥95.2mCN¥110.1mCN¥40.6mCN¥23.6m
Net incomeCN¥30.3mCN¥22.1mCN¥85.3mCN¥61.1mCN¥92.9mCN¥85.4mCN¥74.5mCN¥90.2mCN¥30.6mCN¥14.5m
Diluted earnings per share0.160.150.360.260.350.380.310.390.140.07

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥2.31bnCN¥2.29bnCN¥2.17bnCN¥1.94bnCN¥1.69bnCN¥1.32bnCN¥1.05bnCN¥1.06bnCN¥878.1mCN¥864.2m
Cash and short-term investments—CN¥280.1mCN¥305.8mCN¥186.1mCN¥233.3mCN¥178.8mCN¥80.0mCN¥122.6mCN¥37.4mCN¥86.1m
Total liabilitiesCN¥1.17bnCN¥1.15bnCN¥1.03bnCN¥1.01bnCN¥794.3mCN¥554.6mCN¥371.0mCN¥455.0mCN¥367.3mCN¥383.5m
DebtCN¥423.1mCN¥852.7mCN¥746.3mCN¥756.1mCN¥569.6mCN¥361.9mCN¥193.3mCN¥267.4mCN¥231.5mCN¥284.4m
Shareholders' equityCN¥1.14bnCN¥1.14bnCN¥1.14bnCN¥935.5mCN¥894.0mCN¥745.8mCN¥675.0mCN¥601.5mCN¥510.8mCN¥480.7m
Shares outstanding191m152m240m233m262m225m239m231m213m205m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥133.0m−CN¥23.2mCN¥96.2m−CN¥8.6mCN¥111.1mCN¥50.2mCN¥122.3mCN¥62.0mCN¥63.2mCN¥421.3m
Capital spending−CN¥33.7m−CN¥69.3m−CN¥153.3m−CN¥176.3m−CN¥271.6m−CN¥134.2m−CN¥53.8m−CN¥17.7m−CN¥22.9m−CN¥8.7m
Free cash flowCN¥99.4m−CN¥92.5m−CN¥57.1m−CN¥184.9m−CN¥160.4m−CN¥83.9mCN¥68.5mCN¥44.3mCN¥40.3mCN¥412.6m
Dividends paid−CN¥30.9m−CN¥38.5m−CN¥8.5m−CN¥27.9m−CN¥27.9m−CN¥23.2m−CN¥21.1m−CN¥22.8m−CN¥14.5m−CN¥47.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥575.1mCN¥521.9mCN¥499.0mCN¥464.0mCN¥532.1mCN¥473.8mCN¥530.8mCN¥489.7m
Gross profitCN¥114.3mCN¥92.6mCN¥77.4mCN¥83.6mCN¥73.2mCN¥63.9mCN¥62.0mCN¥80.8m
Operating incomeCN¥55.8mCN¥37.5mCN¥8.8mCN¥15.6mCN¥17.1mCN¥6.6m−CN¥12.7mCN¥15.8m
Net incomeCN¥38.7mCN¥20.2mCN¥6.0mCN¥13.6mCN¥5.5mCN¥5.3m−CN¥14.5mCN¥13.8m
Diluted earnings per share0.200.110.030.070.030.03-0.100.09
Cash from operations———−CN¥6.0mCN¥45.0m−CN¥11.0m—−CN¥28.0m
Capital spending−CN¥1.0m−CN¥15.0m−CN¥16.0m−CN¥6.0m−CN¥4.0m−CN¥6.0m−CN¥64.0m−CN¥3.0m
Free cash flow———−CN¥12.0mCN¥41.0m−CN¥17.0m—−CN¥31.0m
Total assetsCN¥2.33bnCN¥2.35bnCN¥2.31bnCN¥2.34bnCN¥2.32bnCN¥2.26bnCN¥2.29bnCN¥2.35bn
Cash and short-term investments———CN¥332.0mCN¥348.3mCN¥251.6mCN¥280.1mCN¥317.1m
DebtCN¥19.6mCN¥390.1mCN¥423.1mCN¥576.8mCN¥883.7mCN¥781.7mCN¥852.7mCN¥940.6m
Shareholders' equityCN¥1.55bnCN¥1.17bnCN¥1.14bnCN¥1.07bnCN¥1.14bnCN¥1.14bnCN¥1.14bnCN¥1.15bn

Financial ratios

Data as of 17 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2010FY2007
Gross margin78.0%82.6%75.8%72.9%66.8%63.7%———
Operating margin22.5%22.6%36.5%24.9%23.6%27.9%———
Net margin20.5%18.9%31.3%21.6%20.5%25.5%———
Return on equity2.6%2.5%4.5%3.4%3.4%4.8%———
Return on assets2.6%2.4%4.4%3.3%3.3%4.6%———
Free cash flow yield0.8%0.8%1.6%0.6%0.9%1.1%———
Revenue growth-1.4%-9.4%-5.6%-3.3%-8.9%12.2%———
Earnings growth7.0%-45.5%36.6%2.0%-26.7%-3.1%———
Current ratio29.74x30.30x34.94x23.28x21.81x16.17x———
Debt to equity———0.00x0.00x—0.01x0.06x0.23x
Equity ratio97.5%97.3%97.9%96.9%96.8%95.7%———
Interest coverage—105.10x196.99x132.41x128.66x53.28x382.28x——
R&D as a share of sales23.9%23.0%18.6%16.9%30.2%22.0%———
Buybacks as a share of market value-4.3%-6.5%19.8%-25.1%1.9%12.0%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.4%8.6%9.4%
Operating income11.3%-5.0%3.0%
Net income-20.8%-18.7%-4.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin14.6%15.6%16.7%18.7%
Operating margin2.8%3.5%4.6%5.1%
Net margin1.3%2.6%3.5%3.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings65.565.427.529.437.639.224.518.274.2195.1
Price to sales1.00.71.31.01.92.61.51.12.13.2

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 18 Jul 2025.

FY2025FY2024FY2022FY2021FY2020FY2019FY2018FY2017
Paid in the year0.050.100.120.120.100.0910.0450.009
  • 11-for-10 split · 23 May 2019
  • 2-for-1 split · 22 Jul 2014
  • 6-for-5 split · 28 Jun 2013
  • 8-for-5 split · 16 Jul 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.